Samotolisib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Samotolisib, covering 2024-09-04 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]